Marvel Biosciences Initiates Four Week Rat GLP Toxicology Study

Marvel Biosciences Initiates Four Week Rat GLP Toxicology Study

Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to announce that it has initiated the 4-week good laboratory practice (GLP) FDA investigational new drug (IND) enabling dose-ranging rat studies for its lead drug candidate MB-204.

"This rat study, along with the GLP study on dogs, are the last two key studies we need to complete before entering phase 1 human clinical testing of our lead asset - MB-204," said Dr. Mark Williams, Chief Science Officer of Marvel Biosciences. "We are also in the final preparation stage of initiating the 4-week dose-ranging GLP studies on dogs and will update our shareholders on our progress shortly."

"We look forward to completing these two critical studies of MB-204 and entering human trials in the coming months, which is an important value-creating milestone for Marvel and our shareholders," said Rod Matheson, CEO of Marvel Biosciences. "MB-204 to date has shown very promising results, and we believe that this asset has the potential to reduce symptoms of depression and Alzheimer's, both of which are significant and growing problems. We look forward to advancing our lead asset MB-204 through human trials and playing a pivotal role in addressing this growing addressable market."

In the United States, it is estimated that one in ten senior citizens over the age of 65 suffer from dementia. MB-204 is a novel solution to Alzheimer's that has similar properties to the Food and Drug Administration-approved drug, Istradefylline. MB-204 has, through the Company's studies, proven to be more effective and longer lasting than Istradefylline in pre-clinical studies.

MB-204 is a fluorinated derivative of the U.S. FDA-approved adenosine A2a receptor antagonist, Istradefylline. Both Istradefylline and MB-204 are highly active derivatives of caffeine, the most widely consumed psychoactive drug in the world. Caffeine consumption has been associated with a reduced risk of developing Parkinson's disease, and Alzheimer's disease and improved concentration.

About Marvel Biosciences Corp.
Marvel Biosciences Corp., and its wholly owned subsidiary, Marvel Biotechnology Inc., is a Calgary-based pre-clinical stage pharmaceutical development biotechnology company that utilizes a "drug redevelopment" approach to drug development. Historically, when a new class of drug is developed, it is optimized for a particular target, but typically only approved for a specific disease. Often, a new disease is identified which involves the same target, however, pending the remaining patent life, the originally approved drug may not have sufficient time left for it to be commercially viable to be developed for the new disease indication. Marvel develops new synthetic chemical derivatives of the original approved drug for the new disease indication. Patent protection is sought, as the new potential asset is developed by the Company. The Company believes the business model results in significantly less risk, cost and time to develop its assets compared to traditional biotechnology companies.

Marvel Biotechnology Inc. has currently developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.

Contact Information

Investor Relations:
Virtus Advisory Group
Tel: 416-644-5081
Email: info@virtusadvisory.com

Marvel Biosciences Corp.
J. Roderick (Rod) Matheson, Chief Executive Officer or
Dr. Mark Williams, President and Chief Science Officer
Tel: 403 770 2469

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/157765

News Provided by Newsfile via QuoteMedia

MRVL
The Conversation (0)
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021

Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021

The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience

The SNN Network Canada Virtual Event begins on Tuesday, December 7, 2021 with the "MicroCap Investing Workshop" starting at 8:00am EST and featuring well-known financial influencers, investors, fund managers, and key opinion leaders including: Dave Barr, Sharon Wang, Paul Andreola, Becky Popoff, Harold Leishman, Sean MacGillis, and more!

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021

The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience

The SNN Network Canada Virtual Event begins on Tuesday, December 7, 2021 with the "MicroCap Investing Workshop" starting at 8:00am EST and featuring well-known financial influencers, investors, fund managers, and key opinion leaders including: Dave Barr, Sharon Wang, Paul Andreola, Becky Popoff, Harold Leishman, Sean MacGillis, and more!

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
CSE:NUR

NuRAN Wireless Reports Audited Annual Financial Results

NuRAN Wireless Inc. (“NuRAN Wireless” or the “Company”) (CSE:NUR) (OTC:NRRWF) (FSE:1RN) , a leading supplier of mobile and broadband wireless solutions to connect the next billion, is pleased to announce its audited financial results for the twelve months ended October 31, 2018. All dollar amounts are expressed in Canadian currency.

NuRAN Wireless Inc.-Technology Leadership in the Making

Keep reading...Show less
NorthStar Gaming to Host Q3 Earnings Webinar on December 3rd

NorthStar Gaming to Host Q3 Earnings Webinar on December 3rd

NorthStar Gaming Holdings Inc. (TSXV: BET) (OTCQB: NSBBF) ("NorthStar" or the "Company") announces that on December 3rd at 11am ET, the Company's CEO, Michael Moskowitz, will be presenting the Company's third quarter earnings results and an update on current operations and upcoming milestones. The Company expects to announce its third quarter 2024 financial results on November 27, 2024. NorthStar invites all investors and other interested parties to register for the webinar at the link below.

Date: Tuesday, December 3rd, 2024
Time: 11am ET
Register: Webinar Registration

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Bitcoin Well Provides Update to the Bitcoin Super Company Vision and Bitcoin Reserve Fund

Bitcoin Well Provides Update to the Bitcoin Super Company Vision and Bitcoin Reserve Fund

(TheNewswire)

Bitcoin Well Inc.

Edmonton, Alberta November 14, 2024 TheNewswire - Bitcoin Well Inc. (" Bitcoin Well " or the " Company ") ( TSXV: BTCW; OTCQB: BCNWF ), the non-custodial bitcoin business on a mission to enable independence announces an update to the Bitcoin Super Company vision and a strategic bitcoin reserve fund.

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less
Bitcoin Well Reports Q3 2024 Financial Results; Revenue Increased 57% Year Over Year

Bitcoin Well Reports Q3 2024 Financial Results; Revenue Increased 57% Year Over Year

(TheNewswire)

Bitcoin Well Inc.

Edmonton, Alberta TheNewswire - November 12, 2024 Bitcoin Well Inc. (" Bitcoin Well " or the " Company ") ( TSXV: BTCW; OTCQB: BCNWF ), the non-custodial bitcoin business on a mission to enable independence, today announced financial and operating results for the third quarter and nine months ended September 30, 2024.

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less
Troy Minerals Strengthens Leadership Team

Troy Minerals Strengthens Leadership Team

Troy Minerals Inc. ("Troy" or the "Company") (CSE:TROY)(OTCQB:TROYF)(FSE:VJ3) is pleased to announce that following up on its aggressive plans to transition from an exploration company to a cash flow producing company by rapidly advancing its silica projects in North America and Mongolia, it has appointed, Yannis Tsitos, a professional with 35 years' international exploration mining experience and former BHP veteran, as President of the Company

Rana Vig, who to date has served both as President and CEO, owning more than 11% of the Company, will continue to provide his leadership as Chief Executive Officer.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Troy Minerals Targets Restart of Drilling at Tsagaan Zalaa

Troy Minerals Targets Restart of Drilling at Tsagaan Zalaa

Troy Minerals Inc. ("Troy" or the "Company") (CSE:TROY)(OTCQB:TROYF)(FSE:VJ3) is pleased to announce a significant milestone in its ongoing development of the Tsagaan Zalaa Silica Project in Mongolia. With the next phase of drilling now underway, the Company aims to complete the minimum 1,000 meters cumulative drill program, the required threshold for its mining license submission. It should be noted that the silica mineralization at Tsagaan Zalaa is either outcropping or sub-outcropping, resulting is relatively shallow drilling campaigns. The Company expects to complete drilling before year-end, setting the stage for Troy's mining license submission

Located strategically near the Mongolian-Chinese border, the Tsagaan Zalaa Silica Project continues to present robust opportunities for growth in the silica sector, driven by rising demand from green technology and other high-tech industries. The Company remains focused on delivering the necessary operational milestones, aligning with its commitment to achieving first production in the coming year.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Forward Water Technologies Corp. Announces Shares for Interest Debt Settlement

Forward Water Technologies Corp. Announces Shares for Interest Debt Settlement

Forward Water Technologies Corp. ("FWTC" or the "Company") (TSXV:FWTC) is pleased to announce that the Company has arranged a shares for debt transaction to settle an aggregate of $9,453.40 in interest accrued up to September 30, 2024 on $300,000 of indebtedness with GreenCentre Canada (the "Indebtedness

The shares for debt settlement is pending final approval from the TSX Venture Exchange (TSXV) which will be followed by the Company issuing 115,285 common shares ("Settlement Shares") at a deemed price of $0.082 per share to GreenCentre Canada. The terms of the Indebtedness permits the issuance of common shares to settle interest owing by the Company at a deemed issue price per share equal to the five day average closing price for the five days preceding the issuance of the shares and subject to TSXV approval pursuant to TSXV Policy 4.3 - Shares for Debt.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×